Cargando…
Lower ghrelin levels does not impact the metabolic benefit induced by Roux-en-Y gastric bypass
OBJECTIVE: Roux-en-Y gastric bypass is an effective intervention for metabolic disorder. We aim to elucidate whether ghrelin contributes to weight reduction, and glycemic and lipid control after Roux-en-Y gastric bypass (RYGB). DESIGN: Four-week-old WT and Ghrl-TSC1(-/-) mice were fed high fat diet...
Autores principales: | Liang, Yuan, Yu, Ruili, He, Rui, Sun, Lijun, Luo, Chao, Feng, Lu, Chen, Hong, Yin, Yue, Zhang, Weizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445200/ https://www.ncbi.nlm.nih.gov/pubmed/36082078 http://dx.doi.org/10.3389/fendo.2022.891379 |
Ejemplares similares
-
Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery
por: He, Rui, et al.
Publicado: (2018) -
Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass
por: Laferrère, Blandine, et al.
Publicado: (2018) -
Surgical Treatment of Obesity. Special Mention to Roux-en-Y Gastric Bypass and Vertical Gastrectomy
por: Luesma, María José, et al.
Publicado: (2022) -
Roux-en-Y gastric bypass alters intestinal glucose transport in the obese Zucker rat
por: Meng, Qinghe, et al.
Publicado: (2022) -
Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status
por: Carlsson, Elin Rebecka, et al.
Publicado: (2018)